Acylated piperidine derivatives as melanocortin-4 receptor modulators

Details for Australian Patent Application No. 2007300529 (hide)

Owner Merck & Co., Inc.

Inventors Dellureficio, James P.; Ye, Zhixiong; Bakshi, Raman K.; Jian, Tianying; Hong, Qingmei; Nargund, Ravi P.; Liu, Jian

Agent Spruson & Ferguson

Pub. Number AU-A-2007300529

PCT Pub. Number WO2008/039418

Priority 60/847,494 27.09.06 US

Filing date 24 September 2007

Wipo publication date 3 April 2008

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/039418 Priority application(s): WO2008/039418

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007300531-Novel inhibitors of beta-lactamase

2007300526-Analogs of ghrelin substituted at the Nterminal